Cargando…
CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy
Currently, a new gene editing tool—the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) associated (Cas) system—is becoming a promising approach for genetic manipulation at the genomic level. This simple method, originating from the adaptive immune defense system in prokaryotes, ha...
Autores principales: | Chen, Shuliang, Yu, Xiao, Guo, Deyin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795453/ https://www.ncbi.nlm.nih.gov/pubmed/29337866 http://dx.doi.org/10.3390/v10010040 |
Ejemplares similares
-
Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy
por: Xiao, Qiaoqiao, et al.
Publicado: (2019) -
Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection
por: Hou, Panpan, et al.
Publicado: (2015) -
CRISPR/Cas9-Based Antiviral Strategy: Current Status and the Potential Challenge
por: Lee, Choongho
Publicado: (2019) -
The Impact of CRISPR-Cas System on Antiviral Therapy
por: Bayat, Hadi, et al.
Publicado: (2018) -
HIV-1 inhibition in cells with CXCR4 mutant genome created by CRISPR-Cas9 and piggyBac recombinant technologies
por: Liu, Shuai, et al.
Publicado: (2018)